Protalix BioTherapeutics (PLX) EPS (Basic) (2010 - 2026)
Protalix BioTherapeutics' (PLX) quarterly EPS (Basic) came in at $0.23 in Q1 2026, up 587.5% year-on-year from $0.03 in Q1 2025, and up 604.69% quarter-over-quarter from -$0.05 in Q4 2025.
Protalix BioTherapeutics (PLX) EPS (Basic) (2010 - 2026) Analysis & Trends
Protalix BioTherapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at $0.23 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 587.5% year-over-year to $0.23 in Q1 2026; TTM through Mar 2026 was $0.22, a 99.85% increase from a year earlier, with the FY2025 full-year figure at -$0.06, down 157.82% from the prior year.
- EPS (Basic) climbed to $0.23 in Q1 2026 per PLX's latest filing, from -$0.05 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.24 in Q2 2023 and bottomed at -$0.3 in Q4 2023.
- The 5-year median for EPS (Basic) is -$0.05 (2025), against an average of -$0.01.
- Across the five-year window, EPS (Basic) slumped 350.11% in 2023 and jumped 587.5% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$0.07 in 2022, then slumped by 350.11% to -$0.3 in 2023, then jumped by 149.98% to $0.15 in 2024, then plunged by 130.63% to -$0.05 in 2025, then soared by 604.69% to $0.23 in 2026.
- Per Business Quant, the three latest PLX EPS (Basic) figures stand at $0.23 (Q1 2026), -$0.05 (Q4 2025), and $0.03 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn | 0.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.23 |
| Dec 31, 2025 | -0.05 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | -0.05 |
| Dec 31, 2024 | 0.15 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | -0.30 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | 0.24 |
| Mar 31, 2023 | -0.05 |
| Dec 31, 2022 | -0.07 |
| Sep 30, 2022 | -0.07 |
| Jun 30, 2022 | -0.11 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -0.13 |
| Sep 30, 2021 | -0.09 |
| Jun 30, 2021 | -0.25 |